Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin ten Haaf

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2015
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?Kevin Ten Haaf, Harry J de Koning
Pharmacoeconomics|August 6, 2020
Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung CancerErik F Blom, Kevin Ten Haaf, Harry J de Koning
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2014
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trialsKevin Ten Haaf, Joost van Rosmalen, Harry J de Koning
Lung Cancer (Amsterdam, Netherlands)|December 10, 2019
Trends in lung cancer risk and screening eligibility affect overdiagnosis estimatesErik F Blom, Kevin Ten Haaf, Harry J de Koning
The Lancet. Respiratory Medicine|September 7, 2016
Lung cancer screening: latest developments and unanswered questionsCarlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
Translational Lung Cancer Research|March 15, 2021
Implementation of lung cancer screening: what are the main issues?Carlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
BMJ Open Respiratory Research|May 15, 2020
Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer DatabaseErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
Cancer|February 28, 2019
Treatment capacity required for full-scale implementation of lung cancer screening in the United StatesErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
Annals of the American Thoracic Society|November 2, 2019
Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United StatesErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2024
Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012-2021)Koen de Nijs, Harry J de Koning, Carlijn van der Aalst, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2015
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?Kevin Ten Haaf, Harry J de Koning
Pharmacoeconomics|August 6, 2020
Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung CancerErik F Blom, Kevin Ten Haaf, Harry J de Koning
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2014
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trialsKevin Ten Haaf, Joost van Rosmalen, Harry J de Koning
Lung Cancer (Amsterdam, Netherlands)|December 10, 2019
Trends in lung cancer risk and screening eligibility affect overdiagnosis estimatesErik F Blom, Kevin Ten Haaf, Harry J de Koning
The Lancet. Respiratory Medicine|September 7, 2016
Lung cancer screening: latest developments and unanswered questionsCarlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
Translational Lung Cancer Research|March 15, 2021
Implementation of lung cancer screening: what are the main issues?Carlijn M van der Aalst, Kevin Ten Haaf, Harry J de Koning
BMJ Open Respiratory Research|May 15, 2020
Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer DatabaseErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
Cancer|February 28, 2019
Treatment capacity required for full-scale implementation of lung cancer screening in the United StatesErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
Annals of the American Thoracic Society|November 2, 2019
Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United StatesErik F Blom, Kevin Ten Haaf, Douglas A Arenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2024
Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012-2021)Koen de Nijs, Harry J de Koning, Carlijn van der Aalst, et al.
Pageof 6